BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3556014)

  • 1. Imaging techniques and guidelines for evaluation and follow-up of breast cancer patients.
    Feig SA
    Crit Rev Diagn Imaging; 1987; 27(1):1-16. PubMed ID: 3556014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline staging tests in primary breast cancer: a practice guideline.
    Myers RE; Johnston M; Pritchard K; Levine M; Oliver T;
    CMAJ; 2001 May; 164(10):1439-44. PubMed ID: 11387916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging for breast carcinoma.
    Bassett LW; Giuliano AE; Gold RH
    Am J Surg; 1989 Feb; 157(2):250-5. PubMed ID: 2916740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients.
    Brar HS; Sisley JF; Johnson RH
    Am J Surg; 1993 Feb; 165(2):221-3; discussion 224. PubMed ID: 8427400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of distant metastases in breast cancer].
    Untucht HJ; Wöllgens P
    Z Allgemeinmed; 1973 Dec; 49(34):1687-9. PubMed ID: 4789422
    [No Abstract]   [Full Text] [Related]  

  • 6. [Breast carcinoma--revision of follow-up recommendations. 2: Special diagnostic value of bone scintigraphy, thoracic radiography, liver ultrasonic, mammography and laboratory tests].
    Sauer H; Hölzel D
    Fortschr Med; 1995 May; 113(14):210-4. PubMed ID: 7607590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to guidelines for baseline staging in newly diagnosed localized breast cancer.
    DeMiglio L; Murdoch V; Ivison J; Voutsadakis IA
    Cancer Treat Res Commun; 2020; 22():100160. PubMed ID: 31677495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of bone and liver scans in surveying patients with breast cancer for metastatic disease.
    Evans DM; Wright DJ
    Am Surg; 1987 Oct; 53(10):603-5. PubMed ID: 2823653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Imaging diagnosis of non-lymph node metastasis of bladder carcinoma].
    Altieri V; Setola P; Ottaviano N; Ucciero G; Scognamiglio G; Montanaro V; Giannella R; Rega A; Lotti T
    Arch Ital Urol Androl; 1994 Dec; 66(5):223-8. PubMed ID: 7812300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Horner's syndrome: an ominous sign in breast cancer.
    Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):270-1. PubMed ID: 16412554
    [No Abstract]   [Full Text] [Related]  

  • 11. [Staging of pulmonary cancer, establishment of M1].
    Schnyder P
    Schweiz Med Wochenschr; 1987 Sep; 117(39):1475-80. PubMed ID: 3672084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation.
    Schneider C; Fehr MK; Steiner RA; Hagen D; Haller U; Fink D
    Arch Gynecol Obstet; 2003 Nov; 269(1):9-12. PubMed ID: 14605816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up.
    Rosselli Del Turco M; Palli D; Cariddi A; Ciatto S; Pacini P; Distante V
    JAMA; 1994 May; 271(20):1593-7. PubMed ID: 7848404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.
    Thomson V; Pialat JB; Gay F; Coulon A; Voloch A; Granier A; Guérin JC; Viallon M; Berthezene Y
    Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).
    Schumacher JR; Neuman HB; Chang GJ; Kozower BD; Edge SB; Yu M; Vanness DJ; Si Y; Jacobs EA; Francescatti AB; Spears PA; Havlena J; Adesoye T; McKellar D; Winchester D; Burnside ES; Greenberg CC;
    Ann Surg Oncol; 2018 Sep; 25(9):2587-2595. PubMed ID: 29777402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma.
    Kumar MB; Lu JJ; Loh KS; Chong LM; Soo R; Goh BC; Tan KS; Shakespeare TP
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):688-93. PubMed ID: 14967421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How far investigations for occult metastases in breast cancer aid the clinician.
    Glynne-Jones R; Young T; Ahmed A; Ell PJ; Berry RJ
    Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):65-72. PubMed ID: 2031885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of intensive follow-up testing in breast cancer cases.
    Roselli Del Turco M; Palli D; Cariddi A; Ciatto S; Pacini P; Distante V
    Ann Oncol; 1995; 6 Suppl 2():37-9. PubMed ID: 8547195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
    Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening tests to evaluate distant metastases in head and neck cancer.
    Ferlito A; Buckley JG; Rinaldo A; Mondin V
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(4):208-11. PubMed ID: 11408813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.